Genetics and therapy type determine second cancer risk after childhood treatment, study finds

Scientists at St. Jude Children’s Research Hospital have found that genetics and type of cancer treatment contribute most to a survivor’s risk of a second cancer.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup